showed that the overexpression of CXCL9 and CXCL10 revealed a significant correlation with increased NK cells and their migration in late B‐cell lymphoma stages, which were prerequisites for the potential tumor therapy of adoptive NK‐cell transfer 50. This evidence concerns the gene CXCL9 and B-cell non-Hodgkin lymphoma.